Moleculin Biotech's total assets for Q4 2025 were $22.13M, an increase of 8.71% from the previous quarter. DE:MOL0 total liabilities were $7.12M for the fiscal quarter, a -84.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.